SCHEMBL7959999

SCHEMBL7959999

O=C(O)c1cccc(C2=CCCCC2Cc2nc(-c3ccccc3)c(-c3ccccc3)o2)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 5/20 0.70
PTGIR P43119 4/20 0.70
PTGER1 P34995 1/20 0.70
PTGER3 P43115 1/20 0.51
NR4A2 P43354 13/20 0.45
NR4A1 P22736 2/20 0.45
NR4A3 Q92570 2/20 0.45
RXRA P19793 7/20 0.43
RXRB P28702 6/20 0.43
RXRG P48443 5/20 0.43
KDM4E B2RXH2 1/20 0.43
ABCC4 O15439 1/20 0.43
C5 P01031 1/20 0.43
LMNA P02545 1/20 0.43
CHRM2 P08172 1/20 0.43
CYP3A4 P08684 1/20 0.43
CHRM1 P11229 1/20 0.43
DRD2 P14416 1/20 0.43
HPGD P15428 1/20 0.43
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7949263 0.90 PTGER4 (0.58) PTGER4PTGIRPTGER1PTGER3NR4A2
SCHEMBL7960055 0.83 PTGIR (1.00) PTGER4PTGIRPTGER1PTGER3NR4A2
SCHEMBL4576000 0.83 PTGIR (1.00) PTGER4PTGIRPTGER1PTGER3NR4A2
SCHEMBL1626140 0.83 PTGIR (1.00) PTGER4PTGIRPTGER1PTGER3NR4A2
SCHEMBL7964265 0.82 RXRA (0.52) PTGER4PTGIRPTGER1PTGER3NR4A2
SCHEMBL8129795 0.81 PTGER4 (0.52) PTGER4PTGIRPTGER1PTGER3NR4A2
SCHEMBL7960399 0.80 PTGIR (0.94) PTGER4PTGIRPTGER1PTGER3NR4A2
SCHEMBL7961741 0.79 PTGIR (0.93) PTGER4PTGIRPTGER1PTGER3NR4A2
SCHEMBL7961736 0.79 PTGIR (0.93) PTGER4PTGIRPTGER1PTGER3NR4A2
SCHEMBL8126755 0.77 PTGIR (0.83) PTGER4PTGIRPTGER1PTGER3NR4A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6245790-B1 ANTIINFLAMMATORY AGENTS; GASTROINTESTINAL DISORDERS; SKN DISORDERS; BONE DISORDERS; MUSCLE RELAXANTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-06-12 US disclosed
EP-0989975-A1 OXAZOLE COMPOUNDS USEFUL AS PGE2 AGONISTS AND ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-04-05 EP disclosed
WO-1998055468-A1 OXAZOLE COMPOUNDS USEFUL AS PGE2 AGONISTS AND ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-10 WO disclosed